Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB Quarterly Results  (REDY)



Here are the latest quarterly results of DR. REDDYS LAB. For more details, see the DR. REDDYS LAB financial fact sheet and DR. REDDYS LAB share price. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

DR. REDDYS LAB Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-24
*
3
Sep-24
*
3
Dec-24
*
3
Mar-25
*
3
Jun-25
*
3
Sep-25
*
3
Dec-25
*
3
Mar-26
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m76,96180,38283,81285,28485,72188,28387,53475,464 
Other income Rs m1,8723,0751,5025,2212,9033,2392,6884,754 
Turnover Rs m78,83383,45785,31490,50588,62491,52290,22280,218 
Expenses Rs m55,66259,61761,08265,30563,98568,18468,65971,639 
Gross profit Rs m21,29920,76522,73019,97921,73620,09918,8753,825 
Depreciation Rs m3,8063,9704,7144,5474,7615,0465,2105,571 
Interest Rs m5987578176568309079441,057 
Profit before tax Rs m18,76719,11318,70119,99719,04817,38515,4091,951 
Tax Rs m4,9025,7554,7014,1854,9514,0803,536-216 
Profit after tax Rs m13,86513,35814,00015,81214,09713,30511,8732,167 
Gross profit margin %27.725.827.123.425.422.821.65.1 
Effective tax rate %26.130.125.120.926.023.522.9-11.1 
Net profit margin %18.016.616.718.516.415.113.62.9 
Diluted EPS Rs 16.6 16.0 16.8 18.9 16.9 15.9 14.2 2.6  
Diluted EPS (TTM) Rs 66.5 64.8 65.0 68.3 68.6 68.5 66.0 49.7  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster


 

Today's Market

Sensex Today Trades Lower | Nifty Below 23,400 | Kalyan Jewellers Down 6% Sensex Today Trades Lower | Nifty Below 23,400 | Kalyan Jewellers Down 6%(10:30 am)

Asian markets traded lower on Wednesday, following overnight losses on Wall Street, amid concerns over higher oil prices and the ongoing Middle East conflict.